Biotech Bull Market Takes A Hit: Considerable Technical Damage
Remain Cautious Through Q3 Earnings Cycle
Here are some positive and negative indicators to consider on the future direction of biotechnology stocks. We are approaching positive seasonality for the life science sector so we should see a rally after the election through mid-January. Specialist funds control much of the action so we may have to wait for their cue.
No Comments